Cramer's Lightning Round: ‘I do not dig RIG' [CNBC]

Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: CNBC
Anavex Life Sciences : ”...It is, indeed, a spec.” Sarepta Therapeutics : ”...It is troubling, I don't want to be there.” Viking Therapeutics : “I want you to sell Viking Therapeutics and roll it into Viking Holdings.” Transocean : “No, no, no. I do not dig RIG.” DuPont de Nemours : “I say you hold on to DuPont, it's very cheap versus the rest of the group.” Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter. Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market. Disclaimer Questions for Cramer? Call Cramer: 1-800-743-CNBC Want to take a deep dive into Cramer's world? Hit him up! Mad Money Twitter Jim Cramer Twitter Facebook Instagram Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $102.00 price target on the stock.MarketBeat
- Why Viking Therapeutics Inc. (VKTX) Went Down on Monday [Yahoo! Finance]Yahoo! Finance
- 2 Stocks to Buy With Less Than $40 [Yahoo! Finance]Yahoo! Finance
- 2 Stocks That Could Soar Again in 2025 [Yahoo! Finance]Yahoo! Finance
- Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/5/25 - Miss
VKTX
Sec Filings
- 2/5/25 - Form 8-K
- 2/4/25 - Form SCHEDULE
- 1/6/25 - Form 4
- VKTX's page on the SEC website